​Dr. Rimal Mousa participated as a member of the Drug Pricing Committee in a two-day workshop aimed at formulating healthcare policies for pricing non-reference drugs, conducting economic evaluations, and decision-making mechanisms for rare drugs. The workshop was attended by the President of the Jordan Food and Drug Administration, Dr. Nizar Muhaidat, along with directors and officials from various departments."